Laryngeal papillomatosis: immunologic and viral basis for therapy.
The distressing nature of laryngeal papillomatosis and lack of clinical progress in its treatment are reviewed. Presently accepted and investigative methods of therapy are reviewed with special attention being given to immune therapy. Support for the concept of a viral etiology is discussed and other etiologic agents considered. Known and possibly significant roles of wart virus antibodies are discussed and the importance of complex interplay between maternal and fetal immune systems explored as a possible explanation for some puzzling aspects of laryngeal papillomatosis. Finally, a proposed experimental design is outlined, the purpose of which is to provide a useful animal model to investigate immune changes in laryngeal papillomatosis, as well as effects of surgical or medical therapy.
D000328:Adult; D000818:Animals; D002648:Child; D004195:Disease Models, Animal; D005260:Female; D005350:Fibroma / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007822:Laryngeal Neoplasms / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D011247:Pregnancy; D011817:Rabbits; D014777:Virus Diseases / Q000150:complications; D014860:Warts / Q000276:immunology